NYU researchers used focused sound waves on a deep brain target and saw delusions ease after a single 10-minute session in patients whose symptoms resisted medication.
Story Highlights
- NYU’s pilot study used a sham-controlled, within-person design to test brain ultrasound in schizophrenia.
- A single 10-minute focused session reduced delusion scores versus sham, with the gap lasting one week.
- The treatment aimed at the globus pallidus interna using magnetic resonance imaging guidance.
- The sample was small and effects were modest, but short-term safety looked similar to sham.
What The Study Did And Why It Matters
NYU Langone Health ran a small, carefully controlled test of focused ultrasound for people with schizophrenia or schizoaffective disorder who still had symptoms on medication. Each of the 10 participants received two sessions one week apart. One was real ultrasound and one was a sham, with the device placed but sound waves blocked. This “within-person” setup helps reduce noise from patient differences and tightens the comparison of real versus sham effects.
Researchers guided the ultrasound using magnetic resonance imaging to target the right globus pallidus interna, a deep brain node tied to circuits for movement, thought, and emotion. The team delivered a single 10-minute session. NYU reported that delusion scores fell by an average of 1.2 points after the active session, while they rose by 0.4 points after sham. The difference held through the one-week follow-up window, pointing to a short-term signal specific to delusions.
What The Results Show — And Do Not Show
The finding suggests focused ultrasound can nudge brain circuits in a way that reduces delusions, at least briefly, in some patients who need more help than medicines alone provide. Reported side effects were mild and short-lived, like fatigue, headache, or brief symptom bumps, and did not differ between active and sham sessions. That pattern supports near-term safety in this small group, which is a key first step before any larger, longer trials move ahead.
The evidence remains early. Only 10 people took part, and they each received only one active session. The average benefit on delusion scores was modest, and NYU did not report broad gains across other symptom areas, daily function, or thinking skills in this release. The institution summarized the results before full tables and code were provided publicly, so outside analysts cannot yet review all statistics and patient-level patterns.
How This Fits A Bigger Mental Health Trend
Focused ultrasound is drawing interest across psychiatry because it is noninvasive, can reach deep brain targets, and may adjust activity in precise circuits. Reviews describe a promising but unsettled field: a few randomized trials show benefits for specific symptoms, while much of the literature is small, mixed, and short term. That means the NYU signal lines up with a broader pattern of early device studies that look hopeful, then face bigger tests in the next phase.
Ultrasound to cure schizophrenia
Scientists are actively conducting experiments using focused ultrasound (a form of sound waves) to modulate brain circuits in people with schizophrenia, with promising but very preliminary results. This is not a proven cure; it is experimental…
— Gayle Forbess (@GayLou1953) October 22, 2026
The next steps are clear. Larger, sham-controlled, multisite trials should repeat sessions, extend follow-up, and measure function, quality of life, and cognition. Teams should test whether patients or staff can tell active from sham, and release full data and code for independent checks. Researchers can also link symptom change to brain connectivity shifts to confirm the mechanism. These steps will show whether this early result grows into a real treatment option at scale.
Why People Across The Spectrum Care
Families want options that work and do not cost a fortune or require surgery. Clinicians want tools that help when drugs fall short. Policymakers want relief for systems strained by mental illness, homelessness, and lost work. In a time when many feel government and large systems stumble, practical advances that are safe, targeted, and affordable matter. If focused ultrasound holds up, it could add a new, clinic-based option that helps people regain control of their lives.
Sources:
nypost.com, nyulangone.org, cdn.clinicaltrials.gov
